Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

Completed · Not applicable

Conditions studied: Adherence to Medication Regime, Cancer

In brief

Many people treated for cancer receive oral chemotherapy medications for their illness. This means that much of their cancer care occurs at home, away from a traditional oncology care setting. The purpose of this study is to explore how a Smartphone mobile application ("mobile app") can help improve the cancer treatment process in people who are prescribed oral chemotherapy medication. The investigators will explore how well the mobile app helps patients stay connected with their oncology care team, take their oral medications as prescribed, and manage their cancer-related symptoms from home. This study will be done in two phases: 1) a pilot phase to assess the feasibility of a mobile application intervention, and 2) a randomized-controlled trial to test the intervention.

Key facts

Study ID

NCT02157519

Run by

Massachusetts General Hospital

People needed

212

Starts

2015-02-18

Expected to finish

2016-12-31

Last updated by the study team

2018-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient Participant Inclusion Criteria
• Age greater than 18 years
• Diagnosis of cancer with a new or existing prescription for oral chemotherapy
• Receiving cancer care at either Massachusetts General Hospital Cancer Center or community affiliates (North Shore or Emerson Hospitals)
• Eastern Cooperative Oncology Group (ECOG) ranging from 0 (asymptomatic) to 2 (symptomatic and in bed >50% of the day)
• Able to read and respond to questions in English
• Uses smart mobile phone (either operating system (iOS) [iPhone] or Android device)
• Clinician Participant Inclusion Criteria - Clinician participants must be oncology clinicians (i.e. physicians and nurse practitioners) who maintain at least 25% clinical practice at the Massachusetts General Hospital Cancer Center or one of its community affiliates at the North Shore or Emerson Hospital.
• Stakeholder Participant Inclusion Criteria - Four groups of stakeholders will provide ongoing feedback about the study design, methods, and results. To be eligible as a stakeholder, the participant must be able to represent the interests and perspective of at least one of the following stakeholder groups:
• Oncology Patient or Family Member
• Oncology Clinician (e.g., Physician or Nurse Practitioner)
• Cancer Practice Setting Administrator Health System, Community, and Society.

You may not qualify if…

• Patient Participant Exclusion Criteria
• Individuals with co-morbid acute or untreated psychiatric symptoms (e.g., psychosis) or neurologic dysfunction will be excluded given that such symptoms would interfere with consent and participation.
• Individuals who own Windows or Blackberry smart mobile phones will not be eligible.

Where it is running

• Massachusetts General Hospital/North Shore Cancer Center — Boston, Massachusetts, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Massachusetts General Hospital At Emerson Hospital-Bethke — Concord, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.